跳至主要内容
临床试验/NCT03688269
NCT03688269已完成3 期

Determination of the Minimal Effective Concentration (EC90) of Ropivacaine in Axillary Brachial Plexus Block With Intravenous Dexamethasone or Saline Injection

Centre Hospitalier Universitaire de Besancon1 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2018年10月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
146
试验地点
1
主要终点
Surgical Effectiveness of regional anesthesia at 30min

研究概览

简要总结

Prospective up and down sequential evaluation of the minimal effective concentration of perineural ropivacaine for 90% success in axillary brachial plexus block with the injection of intravenous dexamethasone or saline placebo during regional anesthesia performance

详细描述

ropivacaine concentration determined by up and down sequential method dexamethasone or saline placebo determined by randomisation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years old or older
  • ASA Score 1,2 et 3 (American Society of Anesthesiologists Score)
  • surgery under axillary brachial plexus block
  • signed information consent

排除标准

  • pregnancy and breastfeeding
  • contraindication to regional anesthesia or technical impossibility
  • impaired coagulation
  • delay of surgery to short to allow regional anesthesia
  • dementia or under administrative supervision
  • allergy and contraindication to dexamethasone or ropivacaine
  • total dose of ropivacaine higher than 3 mg / kg (recommended dose for upper limb regional anesthesia)
  • opioids or pain killers abuse or addiction
  • steroids consumption in the past 6 months
  • surgery estimated to be greater than 4 hours
  • anticipated bad observation of treatment
  • patient enrolled in another trial

研究组 & 干预措施

Intravenous dexamethasone

Experimental

Axillary Brachial Plexus Block with perineural Ropivacaine. Concentration determined by sequential up and down method.

Intravenous injection of 8mg/2ml Dexamethasone during the regional anesthesia

干预措施: Intravenous dexamethasone (Drug)

Intravenous dexamethasone

Experimental

Axillary Brachial Plexus Block with perineural Ropivacaine. Concentration determined by sequential up and down method.

Intravenous injection of 8mg/2ml Dexamethasone during the regional anesthesia

干预措施: Perineural ropivacaine (Drug)

Intravenous saline

Placebo Comparator

Axillary Brachial Plexus Block with perineural Ropivacaine. Concentration determined by sequential up and down method.

Intravenous injection of 2ml Saline 0.9% during the regional anesthesia

干预措施: Intravenous saline (Drug)

Intravenous saline

Placebo Comparator

Axillary Brachial Plexus Block with perineural Ropivacaine. Concentration determined by sequential up and down method.

Intravenous injection of 2ml Saline 0.9% during the regional anesthesia

干预措施: Perineural ropivacaine (Drug)

结局指标

主要结局

Surgical Effectiveness of regional anesthesia at 30min

时间窗: Time of surgery

Ability to perform surgery under regional anaesthesia without supplementary anaesthesia

次要结局

  • time between regional anesthesia and surgical incision(Time of surgery)
  • Effectiveness of regional anaesthesia on motor function(Time of anaesthesia)
  • recovery of regional anesthesia: pain(first 48h)
  • complication related to regional anesthesia and/or intravenous dexamethasone(month 6)
  • Effectiveness of regional anaesthesia on Pin-Prick sense(Time of anaesthesia)
  • Effectiveness of regional anaesthesia on cold sensation(Time of anaesthesia)
  • recovery of regional anesthesia: motor(first 48h)
  • recovery of regional anesthesia: sensory(first 48h)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Minimal Effective Concentration (EC90) of Ropivacaine | 临床试验